대한방사성의약품학회
ACADEMIC JOURNAL

On-line Submission

ɻ



 

ȣ

ȣ

164

9704F2

Radioiodination strategies for carborane compounds()

06-17 16:03

簡(acceptance)

163

BF0519

Antibody radiolabeling with diagnostic Cu-64 and therapeutic Lu-177 radiometal()

06-17 15:56

簡(acceptance)

162

F5A909

Recent advances in [18F]F-DPA as a promising translocator protein ligand for PET study()

06-13 15:24

簡(acceptance)

161

1CFEF8

Development of evaluation of B/F benzothiazole analogues for boron neutron capture therapy()

06-03 13:52

簡(acceptance)

160

2B5289

()Validation of the production quality and therapeutic efficacy of 47Sc through its anti-cancer effects against EGFR-targeted non-small cell lung cancer.

04-13 16:42

簡(acceptance)

159

580E17

Radiolabeled Benzamide Derivatives for Development of Malignant Melanoma Imaging Agents()

03-24 21:11

簡(acceptance)

158

AB34A5

_Automated radiosynthesis for the routine production of [18F]FPEB for imaging metabotropic glutamate receptor 5 (mGluR5)

12-31 10:20

簡(acceptance)

157

733C17

Development of an exclusive column method for 82Sr/82Rb generator using a 100 MeV proton linear accelerator of KOMAC_

12-22 12:56

簡(acceptance)

156

E8ADD2

Synthesis of 18F−labeled 2−cyanobenzothiazole derivative for efficient radiolabeling of N−terminal cysteine−bearing biomolecules_

12-21 14:23

簡(acceptance)

155

E2A00E

Study on radiolabeling method of chitosan to improve the radiolabeling yield of the final product_

12-21 12:47

簡(acceptance)

154

FE987B

Calix-Arene Based Phase Transfer Catalysts for Nucleophilic Fluorination_

12-20 11:02

簡(acceptance)

153

5ED646

Comparison and evaluation of 89Zr-labeled trastuzumab and Thio- trastuzumab: a potential immuno-PET probe for HER2-positive carcinomas_

12-16 16:18

簡(acceptance)

152

A8A936

Molecular Imaging Application of Iron Oxide Nanoradiomaterial_

12-16 13:20

簡(acceptance)

151

ED1A82

Facile Metal-Free Direct Transformation of N-Allyl- and tert-Butyl-Protected Arylamines to Azacycles Using Phosphoryl Chloride

12-16 10:00

(rejection)

150

E7D8CA

Development of Radiolabeled Somatostatin Derivatives for Neuroendocrine Tumors_

12-14 12:01

簡(acceptance)

 

 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15